Cresco Labs Inc. (CRLBF)
USD 0.94
(0.43%)
USD 0.94
(0.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 59.63 Million | 18.74 Million | 14.48 Million | -10.83 Million | -25.18 Million | -9.91 Million |
| Net Income | -178.74 Million | -215.84 Million | -296.83 Million | -36.56 Million | -65.3 Million | 3.09 Million |
| Depreciation & Amortization | 70.57 Million | 57.72 Million | 44.94 Million | 40.01 Million | 11.91 Million | 2.17 Million |
| Deferred income taxes | -33.25 Million | -4.64 Million | -34.93 Million | -4.44 Million | 1.17 Million | 1.51 Million |
| Stock-based compensation | 16.35 Million | 23.22 Million | 27.53 Million | 18.83 Million | 14.86 Million | 10.46 Million |
| Change in working capital | 15.49 Million | 13.45 Million | -29.06 Million | 2.96 Million | 21.88 Million | -1.01 Million |
| Other non-cash items | 169.2 Million | 144.82 Million | 302.83 Million | -31.3 Million | -9.72 Million | -26.14 Million |
| Investing Cash Flow | -45.4 Million | -36.57 Million | -163.93 Million | -44.11 Million | -107.59 Million | -81.78 Million |
| Investments in PPE | -58.94 Million | -86.13 Million | -97.05 Million | -80.37 Million | -96.12 Million | -29.94 Million |
| Acquisitions | 11.91 Million | -1.13 Million | -75.74 Million | -14.76 Million | -31.7 Million | -37.07 Million |
| Investment purchases | - | - | - | - | -2.85 Million | -901 Thousand |
| Sales/Maturities of investments | - | - | - | - | 38.53 Million | -782 Thousand |
| Other Investing Activities | 1.62 Million | 50.69 Million | 8.86 Million | 51.03 Million | -15.44 Million | -13.07 Million |
| Financing Cash Flow | -27.4 Million | -86.64 Million | 235 Million | 142.67 Million | 48.9 Million | 202.68 Million |
| Debt repayment | -17.84 Million | -2.42 Million | -226.25 Million | -17.89 Million | -5.02 Million | -1.05 Million |
| Dividends payments | - | - | - | -162 Thousand | -3.01 Million | - |
| Common Stock Repurchased | - | - | -143 Thousand | 192.2 Million | 3.01 Million | - |
| Common Stock Issuance | - | 3.08 Million | 124.1 Million | 3.52 Million | 55.47 Million | 205.9 Million |
| Other Financing Activities | -9.55 Million | -87.3 Million | 337.43 Million | -34.99 Million | -1.54 Million | -2.17 Million |
| Accounts receivables | -5.46 Million | -14.77 Million | -10.96 Million | -5.25 Million | -12.78 Million | -2.58 Million |
| Accounts payables | 28.3 Million | 10.7 Million | 21.15 Million | -6.52 Million | 36.51 Million | 2.95 Million |
| Inventory | 23.92 Million | -2.66 Million | -18.42 Million | -297.19 Million | -109.6 Million | -45.49 Million |
| Other working capital | -31.26 Million | 20.19 Million | -20.84 Million | 311.94 Million | 107.74 Million | 44.11 Million |
| Cash at beginning of period | 121.45 Million | 226.1 Million | 140.77 Million | 54.15 Million | 138.02 Million | 27.04 Million |
| Cash at end of period | 107.96 Million | 121.51 Million | 226.1 Million | 140.77 Million | 54.15 Million | 138.02 Million |
| Capital Expenditure | -58.94 Million | -86.13 Million | -97.05 Million | -80.37 Million | -96.12 Million | -29.94 Million |
| Effect of forex changes on cash | -62 Thousand | -113 Thousand | -231 Thousand | -1.1 Million | - | - |
| Net cash flow / Change in cash | -13.49 Million | -104.59 Million | 85.32 Million | 86.62 Million | -83.87 Million | 110.98 Million |
| Free Cash Flow | 693.48 Thousand | -67.39 Million | -82.56 Million | -91.2 Million | -121.31 Million | -39.86 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -54.32 Million | -5.16 Million | 2.7 Million | -178.74 Million | -114.1 Million | -43.46 Million |
| Depreciation & Amortization | 16.43 Million | 17.21 Million | 22.56 Million | 70.57 Million | 16.78 Million | 15.69 Million |
| Deferred income taxes | 2.97 Million | 936.79 Thousand | -7.3 Million | -33.25 Million | -24.66 Million | 326 Thousand |
| Stock-based compensation | 3.47 Million | 4.19 Million | 3.01 Million | 16.35 Million | 4.07 Million | 2.2 Million |
| Change in working capital | -14.42 Million | 10.54 Million | -28.45 Million | 15.49 Million | 21.23 Million | 17.2 Million |
| Other non-cash items | 104.99 Million | 49.46 Million | 4.24 Million | 169.2 Million | 166.48 Million | 26 Million |
| Investing Cash Flow | -10.23 Million | -5.65 Million | 2.55 Million | -45.4 Million | -12.47 Million | -14.05 Million |
| Investments in PPE | -7.14 Million | -6.52 Million | -5.38 Million | -58.94 Million | -13.22 Million | -18.18 Million |
| Acquisitions | -3.2 Million | 395.22 Thousand | 6.77 Million | 11.91 Million | 152.39 Thousand | 4.94 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 108.71 Thousand | 475.86 Thousand | 1.16 Million | 1.62 Million | 597.22 Thousand | -804.39 Thousand |
| Financing Cash Flow | -15.79 Million | -11.09 Million | -3.89 Million | -27.4 Million | 10.05 Million | -19.54 Million |
| Debt repayment | -147.52 Thousand | -217.02 Thousand | -181.64 Thousand | -17.84 Million | -17.79 Million | -806 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -200 Thousand | - | - | - | - |
| Common Stock Issuance | 6963.63 | 1991.07 | - | - | - | - |
| Other Financing Activities | -14.72 Million | -10 Million | -3.71 Million | -9.55 Million | 27.84 Million | -18.73 Million |
| Accounts receivables | -4.38 Million | 1.95 Million | 3.5 Million | -5.46 Million | -2.11 Million | -10.51 Million |
| Accounts payables | -5.21 Million | -6.87 Million | -11.63 Million | 28.3 Million | 7.66 Million | 11.41 Million |
| Inventory | 4.11 Million | 2.66 Million | 8.66 Million | 23.92 Million | 2.54 Million | 12.14 Million |
| Other working capital | -8.94 Million | 12.8 Million | -28.98 Million | -31.26 Million | 13.13 Million | 4.15 Million |
| Cash at beginning of period | 124.77 Million | 107.96 Million | 112.47 Million | 121.45 Million | 74.81 Million | 90.45 Million |
| Cash at end of period | 115.93 Million | 124.77 Million | 107.96 Million | 107.96 Million | 113.01 Million | 74.81 Million |
| Capital Expenditure | -7.14 Million | -6.52 Million | -5.38 Million | -58.94 Million | -13.22 Million | -18.18 Million |
| Effect of forex changes on cash | -10 Thousand | -13 Thousand | -21 Thousand | -62 Thousand | 7000.00 | -22 Thousand |
| Net cash flow / Change in cash | -8.83 Million | 16.8 Million | -4.5 Million | -13.49 Million | 38.2 Million | -15.64 Million |
| Free Cash Flow | 10.15 Million | 29.78 Million | -8.62 Million | 693.48 Thousand | 27.39 Million | -213 Thousand |
5276
4556
2383
ORLY
EVT
DANSKE